MENU

The Department of Science and Technology (DOST)in Region III is now accepting health research project proposals in line with the priorities set by the Central Luzon Health Research and Development Consortium (CHLRDC) for the year 2012.

This was announced by Dr. Victor B. Mariano, regional director of DOST3 and chairperson of CLHRDC. He said that the research proposals must conform with the identified priority areas which include development of diagnostic kits for priority diseases, drug discovery and development, hospital equipment and biomedical equipment, genomic and molecular technology and chronobiology, functional foods and  use of information and communication technology in health management. The CLHRDC is an association of government, private and state colleges and universities organized to strengthen the system of collaboration among health-related institutions in Central Luzon to develop and enhance their capacity to undertake health research projects for the benefit of the local population.It is currently composed of 18 member-agencies.

A total of eight  research proposals have been submitted by member-institutions of CLHRDC.Two proposals aim to address the recurrent problem of dengue fever in Central Luzon. The first deal with the determination of the active components of the tawa-tawa plant as potential inhibitor of NS3 Protease helicase for the dengue virus was submitted by the Nueva Ecija University of Science and Technology (NEUST) and the second seeks to create a geo-spatial profile of dengue in Central Luzon as a means of  building an effective surveillance system that can track the incidence of cases, risks factors and medical consequences of dengue as well as establishing and evaluating prevention intervention which was submitted by Angeles University Foundation (AUF). Another research proposal also submitted by NEUST aims to study the waste management practices of government and private hospitals in Region III in light of heightened awareness about solid waste disposal and their effect on the environment.  A research proposal that aims to stop the emergence of superbugs by studying the methicillin-resistant Staphylococcus aureus (MRSA) antagonists from coconut-based nutraceuticals was submitted by the Tarlac State University.  If successful, the project will provide affordable alternative to the treatment of MRSA.

All research proposals will undergo panel evaluation by the Phil. Council for Health Research and Development (PCHRD), an attached agency of DOST.  Projects that pass the required criteria will be eligible for funding.  Other research institutions may still submit research proposals at the DOST3 regional office located at the Regional Government Center, Maimpis, City of San Fernando, Pampanga.

 
On November 13, 2011, Grand Challenges Canada announced new funding opportunities for early-career innovators from low- and lower-middle income countries, the Rising Stars in Global Health program.
 
 
The application site is now open and we are accepting applications. For more information and to apply, please visit www.grandchallenges.ca
Grand Challenges Canada's goal is to tap into bold local solutions to global health problems to solve some of the most persistent health challenges in the developing world through Integrated Innovation.
 
 
The Rising Stars in Global Health program will provide $100,000 CAD for up to 30 successful proof-of-concept proposals. Up to 6 additional scale-up grants of up to $1 million CAD will be awarded to applicants who have demonstrated success at the proff-of-concept stage.

Deadline: March 23, 2012 at 11:59 p.m. ET

Please help us by disseminating this opportunity to your colleagues.

Grand Challenges Canada is a unique and indpendent not-for-profit organization dedicated to improving the health and well being of people in developing countries by integrating scientific, technological, business and social innovation. Grand Challenges Canada works with the International Development Research Centre (IDRC) and the Canadian Institutes of Health Research (CIHR) and other global health foundations and organizations to find sustainable long-term solutions to the most pressing health challenges. Grand Challenges Canada is hosted at the McLaughlin-Rotman Centre for Global Health.

If you are not already on our mailing list and would like to keep up-to-date with all the lates developments, including news, publications and job opportunities, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..



The Metro Manila Health Research and Development Consortium (MMHRDC) invites us (CLHRDC) to send participants to the Training-Workshop on Animal Care and Use in Research and Animal Biosafety. This will be held at the UP Manila National Institutes of Health Centennial Conference Room on January 26-27, 2012. This training-workshop is a capacity building initiative of MMHRDC intended for investigators and research advisers involved in researches involving the use of animals. A certificate of training, will be provided to the participants after the completion of the course. .

The objectives of the course are as follows:

a. To promote awareness on the regulations and policies on animal care and use in research;

b. To promote a culture of biosafety in the animal laboratory

c. To capacitate participants with working knowledge and techniques in animal care and use as well as biosafety in the animal laboratory


Among topics for this course include:

* Republic Act 8485: Animal Welfare Act and other regulations

* Role of institutions, investigators and the IACUC

* Housing and animal care requirements

* Techniques and procedures in blood collection, drug administration and euthanasia

* Principles of Biosafety, Animal Biosafety Levels, Practices, Primary and Secondary Containment


To optimize participant learning during the workshops, they are limiting the number of participants. They would appreciate if you could confirm your attendance by paying the registration fee of Php3,500.00 [see flyer for instructions], and fax or email  your deposit slip together with the registration form on or before January 23, 2011. You may also coordinate with the CLHRDC Project Assistant if interested to attend the training.

 

The Central Luzon Health Research and Development Consortium (CLHRDC) is an association of different government line agencies, hospitals and higher educational institutions in Central Luzon that aims at strengthening the collaborative efforts among these institutions, both private and public, in improving the health conditions of  the people through enhanced undertaking of health research and management activities.


The CLHRDC is committed to undertake among others, the identification of priority regional health concerns as set forth by the National Unified Health Research Agenda (NHURA) as well as generate resources for health-related researches. It further aims to develop human resources, facilities and other infrastructure requirements for health and nutrition research activities.
As the lead convenor for the CLHRDC, the DOST III calls for regular meetings to provide directions for the consortium and ensure the accomplishments of activities.


The identified CLHRDC priority areas which are aligned with the DOST-PCHRD and DOH priorities are as follows: (1) point of care (POC) technologies for infectious/tropical and lifestyle related diseases, (2) drug discovery and development,  (3) telemedicine and medical informatics, development of devices for remote diagnosis and monitoring, (4) health service delivery and (5) genomic/molecular technology.


At present, the consortium works on a research entitled “Detection, Treatment and Prevention/Control of Tuberculosis in Region III:  An Assessment” with La Consolacion University Philppines as the project head.


To date, the consortium has seventeen (17) member-institutions which include: Department of Science and Technology III (DOST III), Department of Health, Commission on Higher Education III, Commission on Population, Jose B. Lingad Memorial General Hospital, Paulino J. Garcia Memorial Research Medical Center, Angeles University Foundation, Bataan Peninsula State University, Bulacan State University, Holy Angel University, La Consolacion University Philippines (formerly University of Regina Carmeli), Nueva Ecija University of Science and Technology, Ramon Magsaysay Technological State University, Republic Central Colleges, Systems Plus College Foundation, Tarlac State University and University of the Assumption .
Membership in the consortium is open to interested parties who are required to submit a letter of intent, an endorsement from a founding member-institution of CLHRDC and a survey questionnaire which can be downloaded from the CLHRDC website: http://region3.healthresearch.ph. Benefits of membership in the consortium include:  strengthening of research capabilities through complementation and sharing of resources; access to various human resources and institution development programs/projects of the consortium; and sharing of scientific information through library linkage and similar arrangements.

CALL FOR NOMINATIONS: PCHRD'S OUTSTANDING HEALTH RESEARCH AWARD 2012

 

PURPOSE

The Outstanding Health Research Award (OHRA) encourages researchers to be sensitive to the scientific and technological requirements of the health delivery system and rewards those whose research efforts are relevant to prevalent health problems.

The award gives recognition to the work of an individual or study group who has been able to demonstrate the link between research and practice through the absorption or utilization of his/her research project in the health delivery system.

NOMINATION PROCEDURES:

1. Who can be nominated

All Filipino health researchers, working individually or in groups, can be considered as candidates for the award. Work in either biomedical research or health services research may be considered.

2. Who can nominate

Nominations may be made by individuals, scientific, technological and professional societies or associations, research institutes and universities and colleges. However, self nomination is not allowed.

3. How to nominate

Nominations should be made on the prescribed nomination form. Each nomination should include all of the following:

a.   one copy of each of the technical reports/and publications of the completed projects leading to the technology.
b.   write-up on the impact of the project on health delivery highlighting how the results were utilized and the benefits derived from their utilization.
c.    A statement from the technology user(s) describing the contribution of the technology in improving health delivery.

4. Where to send nominations

a.    Nominations should be submitted to:
Office of the Executive Director
Philippine Council for Health Research and Development
3/F DOST Administration Building
Gen. Santos Avenue, Bicutan, Taguig City, Metro Manila

b.    Nominations should reach PCHRD not later than November 15, 2011

SELECTION:

A.    Criteria for Selection

1.    Extent of Impact on health/ quality of life (30%)

Contributes to the promotion of the well-being of a greater section of the population

Provides long-term solution to health problems affecting majority of the population

Short gestation period for timely application of results


2.    Economic benefits (30%)

Results to savings accruing from import substitution and reduced health care cost

Have the potential for export

Increases productivity

Better allocation/application of health resources is achieved


3.    S & T benefits (40%)

Improves knowledge and/or resolves issues in health problems

Serves as stepping stone for other areas of investigation

B.    Procedure for Selection


1.    Nominations for the Award will be considered by a Screening Committee
composed of distinguished scientists and health practitioners appointed by the PCHRD Governing Council;
2.    The Screening Committee can undertake visits or interview nominees or other
concerned individual to validate statements made in the nomination form.
3.    The decision of the Screening Committee will be final.


INCENTIVES:

The award will consist of a cash prize of P500, 000.00 and a trophy for each of the biomedical research category and health services research category.